Cargando…
Age-specific rate of severe and critical SARS-CoV-2 infections estimated with multi-country seroprevalence studies
BACKGROUND: Knowing the age-specific rates at which individuals infected with SARS-CoV-2 develop severe and critical disease is essential for designing public policy, for infectious disease modeling, and for individual risk evaluation. METHODS: In this study, we present the first estimates of these...
Autores principales: | Herrera-Esposito, Daniel, de los Campos, Gustavo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8962942/ https://www.ncbi.nlm.nih.gov/pubmed/35351016 http://dx.doi.org/10.1186/s12879-022-07262-0 |
Ejemplares similares
-
Bayesian estimation of the seroprevalence of antibodies to SARS-CoV-2
por: Dong, Qunfeng, et al.
Publicado: (2020) -
SARS-CoV-2 Lambda and Gamma variants competition in Peru, a country with high seroprevalence
por: Vargas-Herrera, Natalia, et al.
Publicado: (2021) -
Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020
por: Bajema, Kristina L., et al.
Publicado: (2020) -
Estimates of anti-SARS-CoV-2 antibody seroprevalence in Iran
por: Nazemipour, Maryam, et al.
Publicado: (2021) -
Estimates of anti-SARS-CoV-2 antibody seroprevalence in Iran
por: Ghafari, Mahan, et al.
Publicado: (2021)